Form 8-K - Current report:
SEC Accession No. 0001213900-24-080690
Filing Date
2024-09-20
Accepted
2024-09-20 16:30:13
Documents
14
Period of Report
2024-09-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ea0215303-8k_nkgen.htm   iXBRL 8-K 29968
  Complete submission text file 0001213900-24-080690.txt   253676

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nkgn-20240916.xsd EX-101.SCH 3891
3 XBRL DEFINITION FILE nkgn-20240916_def.xml EX-101.DEF 27227
4 XBRL LABEL FILE nkgn-20240916_lab.xml EX-101.LAB 37684
5 XBRL PRESENTATION FILE nkgn-20240916_pre.xml EX-101.PRE 25848
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0215303-8k_nkgen_htm.xml XML 6170
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 241313748
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)